GB202016659D0 - Methods and compositions for cellular therapy - Google Patents

Methods and compositions for cellular therapy

Info

Publication number
GB202016659D0
GB202016659D0 GBGB2016659.1A GB202016659A GB202016659D0 GB 202016659 D0 GB202016659 D0 GB 202016659D0 GB 202016659 A GB202016659 A GB 202016659A GB 202016659 D0 GB202016659 D0 GB 202016659D0
Authority
GB
United Kingdom
Prior art keywords
compositions
methods
cellular therapy
therapy
cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2016659.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Replay Holdings Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GBGB2016659.1A priority Critical patent/GB202016659D0/en
Publication of GB202016659D0 publication Critical patent/GB202016659D0/en
Priority to JP2023548545A priority patent/JP2023546300A/en
Priority to PCT/US2021/055682 priority patent/WO2022087019A1/en
Priority to CA3196346A priority patent/CA3196346A1/en
Priority to GB2306292.0A priority patent/GB2619410A/en
Priority to AU2021364550A priority patent/AU2021364550A1/en
Priority to KR1020237016408A priority patent/KR20230110258A/en
Priority to EP21883739.1A priority patent/EP4232468A1/en
Priority to US18/303,075 priority patent/US20240124551A1/en
Ceased legal-status Critical Current

Links

GBGB2016659.1A 2020-10-20 2020-10-20 Methods and compositions for cellular therapy Ceased GB202016659D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB2016659.1A GB202016659D0 (en) 2020-10-20 2020-10-20 Methods and compositions for cellular therapy
JP2023548545A JP2023546300A (en) 2020-10-20 2021-10-19 Methods and compositions for cell therapy
PCT/US2021/055682 WO2022087019A1 (en) 2020-10-20 2021-10-19 Methods and compositions for cellular therapy
CA3196346A CA3196346A1 (en) 2020-10-20 2021-10-19 Methods and compositions for cellular therapy
GB2306292.0A GB2619410A (en) 2020-10-20 2021-10-19 Methods and compositions for cellular therapy
AU2021364550A AU2021364550A1 (en) 2020-10-20 2021-10-19 Methods and compositions for cellular therapy
KR1020237016408A KR20230110258A (en) 2020-10-20 2021-10-19 Methods and compositions for cell therapy
EP21883739.1A EP4232468A1 (en) 2020-10-20 2021-10-19 Methods and compositions for cellular therapy
US18/303,075 US20240124551A1 (en) 2020-10-20 2023-04-19 Methods and compositions for cellular therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2016659.1A GB202016659D0 (en) 2020-10-20 2020-10-20 Methods and compositions for cellular therapy

Publications (1)

Publication Number Publication Date
GB202016659D0 true GB202016659D0 (en) 2020-12-02

Family

ID=73598507

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2016659.1A Ceased GB202016659D0 (en) 2020-10-20 2020-10-20 Methods and compositions for cellular therapy

Country Status (1)

Country Link
GB (1) GB202016659D0 (en)

Similar Documents

Publication Publication Date Title
IL288914A (en) Compositions and methods for treating cancer
IL286350A (en) Compositions and methods for treating cancer
EP4136254A4 (en) Ace2-targeted compositions and methods for treating covid-19
IL287982A (en) Compositions and methods for treating cancer
ZA202104870B (en) Methods and compositions for treating cancer
EP4025590A4 (en) Methods and compositions for treating cancer
IL286153A (en) Methods and compositions for treating cancer
GB202111040D0 (en) Compositions and methods
GB202306292D0 (en) Methods and compositions for cellular therapy
EP4110822A4 (en) Compositions and methods for treating cancer
EP4138879A4 (en) Methods and compositions
EP4127722A4 (en) Methods and compositions for treating cancer
EP4084784A4 (en) Compositions and methods
SG11202109336UA (en) Methods and compositions for treating cancer
GB202101665D0 (en) Methods and compositions for cellular therapy
GB202016659D0 (en) Methods and compositions for cellular therapy
IL287538A (en) Compositions and methods for treatment of cancer
IL285036A (en) Methods and compositions for treating cancer
GB202110091D0 (en) Methods and compositions
EP4090337A4 (en) Bcma-directed cellular immunotherapy compositions and methods
GB202205771D0 (en) Methods and compositions for cellular therapy
EP4077690A4 (en) Methods and compositions for treating cancer
EP3999065A4 (en) Therapeutic compositions and methods for treating cancers
GB202300911D0 (en) Therapeutic compositions and methods
GB202219334D0 (en) therapeutic compositions and methods

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: REPLAY HOLDINGS, LLC

Free format text: FORMER OWNER: ADRIAN WOOLFSON

AT Applications terminated before publication under section 16(1)